Last 97.00 INR
Change Today -3.65 / -3.63%
Volume 55.8K
RPGL On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

rpg life sciences ltd (RPGL) Snapshot

Open
93.00
Previous Close
100.65
Day High
105.00
Day Low
93.00
52 Week High
07/3/14 - 122.05
52 Week Low
02/7/14 - 44.60
Market Cap
1.6B
Average Volume 10 Days
179.1K
EPS TTM
32.29
Shares Outstanding
16.5M
EX-Date
--
P/E TM
3.0x
Dividend
1.20
Dividend Yield
1.24%
Current Stock Chart for RPG LIFE SCIENCES LTD (RPGL)

Related News

No related news articles were found.

rpg life sciences ltd (RPGL) Related Businessweek News

No Related Businessweek News Found

rpg life sciences ltd (RPGL) Details

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic dosage forms, and synthetic and fermentation active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic/anti-depressant, anti-thrombotic, anti-anginal, anti-helmentic, anti-convulsant, anti-spasmodic, and anti-cancer. It also provides generics primarily in the area of immunosuppressant therapy; finished dosage formulations for various therapies, such as gastro-intestinal, pain management, cardio-vascular, and nephrology primarily under the Lomotil, Lomofen, Naprosyn, Azoran, Aldactone, and Serenace brand names; and biotechnology products in the areas of oncology. RPG Life Sciences Limited offers its products in various dosage forms, including tablets, capsules, and syrups. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is based in Mumbai, India.

Founded in 1968

rpg life sciences ltd (RPGL) Top Compensated Officers

Managing Director, Director, Member of Audit ...
Total Annual Compensation: 15.3M
Compensation as of Fiscal Year 2013.

rpg life sciences ltd (RPGL) Key Developments

ARPG Life Sciences Limited Announces Unaudited Earnings Results for the Fourth Quarter and Audited Earnings Results for the Full Year Ended March 31, 2014

ARPG Life Sciences Limited announced unaudited earnings results for the fourth quarter and audited earnings results for the full year ended March 31, 2014. For the quarter, net sales/income from operations was INR 511.4 million against INR 563.4 million a year ago. Loss from operation before other income, finance costs and exceptional items was INR 5.5 million against profit from operation before other income, finance costs and exceptional items of INR 49.3 million a year ago. Loss from ordinary activities before tax was INR 6.6 million against profit from ordinary activities before tax of INR 35.3 million a year ago. Net loss was INR 5.1 million as compared to profit of INR 74.0 million of the corresponding quarter of 2013. Basic and diluted earnings per share was INR 0.31 against INR 4.48 a year ago. For the year, net sales/income from operations was INR 2,293.8 million against INR 2,162.1 million a year ago. Profit from operation before other income, finance costs and exceptional items was INR 8.5 million against INR 62.0 million a year ago. Profit from ordinary activities before tax was INR 649.7 million against INR 5.4 million a year ago. Net profit was INR 534.0 million as compared to INR 44.1 million of the corresponding period of 2013. Basic and diluted earnings per share was INR 32.29 against INR 2.67 a year ago.

RPG Life Sciences Ltd Recommends Normal and Special Dividend for the Year Ended March 31, 2014

RPG Life Sciences Ltd. has informed that the Board of Directors of the company at its meeting held on April 30, 2014, recommended a normal dividend of INR 1.20 per share (15%) and a special dividend of INR 0.80 per share (10%) on account of extraordinary income aggregating to total dividend of INR 2.00 per share (25%) for the year ended March 31, 2014, subject to the approval of the members at the ensuing Annual General Meeting.

RPG Life Sciences Limited to Report Fiscal Year 2014 Final Results on Apr 30, 2014

RPG Life Sciences Limited announced that they will report fiscal year 2014 final results on Apr 30, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RPGL:IN 97.00 INR -3.65

RPGL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RPGL.
View Industry Companies
 

Industry Analysis

RPGL

Industry Average

Valuation RPGL Industry Range
Price/Earnings 3.0x
Price/Sales 0.7x
Price/Book 1.3x
Price/Cash Flow 2.5x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RPG LIFE SCIENCES LTD, please visit www.rpglifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.